[Featured Stock] Three Billion Soars Over 20%... Surpasses 7,000 Won Intraday
The stock price of Three Billion, an AI-based genetic disease diagnostic testing company, is showing a strong gain of over 20%.
As of 2:12 PM on the 17th, just before the market close, Three Billion's stock is trading at 6,970 KRW per share, up 22.93% compared to the previous trading day. During the session, the price briefly surpassed 7,000 KRW per share.
This surge is attributed to the news that the company signed a memorandum of understanding (MOU) for genetic testing cooperation with Korea AstraZeneca before the market opened, which triggered buying interest.
Hot Picks Today
"450,000 Deaths Expected by Early Next Year"... World's Worst-Ever El Nino Forecast Spurs Global Alarm
- "Much Has Changed Since You Left, Please Come Back"... Amazon Surprises by Actively Rehiring Former Employees
- Husband Gave 2 Million Won to His Parents, Only a 100,000 Won Gift to Wife’s Family... Divorce Lawsuit Follows
- "It's Nothing to Kill You"... Seungri Caught on CCTV Swinging Soju Bottle
- 'Terror at 2:40 a.m.'... Suspects Wrecked and Fled After an Hour in Bundang Chinese Restaurant Ordeal
Through this collaboration, Three Billion and AstraZeneca plan to establish a genetic testing system capable of completing diagnosis within two weeks for patients with atypical hemolytic uremic syndrome (aHUS), a rare disease.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.